<DOC>
	<DOCNO>NCT00673348</DOCNO>
	<brief_summary>Voriconazole ( VCZ ) , antifungal drug active Candida Aspergillus substrate CYP2C19 , whose proportion poor metabolizers ~20 % Asian population . The AUC 's VCZ differ 4 fold CYP2C19 genotypes homozygotic wild type , heterozygote , homozygotic poor metabolizers . The Asian population enrol metabolism VCZ mainly Japanese Chinese , without Korean subject . The proportion poor metabolizers Korean population know around 12 % ( Pharmacogenetics . 1996 Dec ; 6 ( 6 ) :547-51 ) . The importance CYP2C19 genotypes pharmacokinetics ( PK ) voriconazole well establish , Hence , desirable individualize dosage regimen VCZ accord genotype patient . Fungal infection immunocompromised patient life threaten condition need critical care . Although PK change genotype well know , clinical implication need different dosage regimen genotype establish , yet .</brief_summary>
	<brief_title>Therapeutic Drug Monitoring ( TDM ) Voriconazole Correlation With CYP2C19 Genotype Korean Populations</brief_title>
	<detailed_description>The investigator try set voriconazole ( VCZ ) therapeutic drug monitoring ( TDM ) &amp; establish relationship efficacy safety Korea . The investigator also want propose optimal dosage regimen VCZ different genotype CYP2C19 immunocompromised patient Korea .</detailed_description>
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Neutropenia</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Immunocompromised adult treat voriconazole due proven probable invasive fungal infection Patients treat investigational drug Patients liver dysfunction ( aminotransferase level â‰¥ 5 time upper limit normal , bilirubin alkaline phosphatase level &gt; 3 time upper limit normal ) Patients renal dysfunction ( Cr level &gt; 2.5 time upper limit normal ) Pregnant woman Patients young 15 year age</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Mycoses</keyword>
	<keyword>Voriconazole</keyword>
</DOC>